SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-015017
Filing Date
2023-05-18
Accepted
2023-05-18 07:00:40
Documents
28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20230515_def14a.htm   iXBRL DEF 14A 726686
6 b01.jpg GRAPHIC 44433
7 gph01.jpg GRAPHIC 195544
8 gph02.jpg GRAPHIC 164300
9 i01.jpg GRAPHIC 766
10 i02.jpg GRAPHIC 770
11 i04.jpg GRAPHIC 794
12 img02.jpg GRAPHIC 35628
13 img.jpg GRAPHIC 776
14 nby20230503_pre14aimg001.jpg GRAPHIC 5110
15 nby20230503_pre14aimg002.jpg GRAPHIC 2297
16 nby20230503_pre14aimg003.jpg GRAPHIC 3495
17 nby20230503_pre14aimg004.jpg GRAPHIC 3120
18 nby20230503_pre14aimg005.jpg GRAPHIC 5110
19 nby20230503_pre14aimg008.jpg GRAPHIC 2243
  Complete submission text file 0001437749-23-015017.txt   2541802

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20221231.xsd EX-101.SCH 6973
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20221231_def.xml EX-101.DEF 8771
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20221231_lab.xml EX-101.LAB 17218
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20221231_pre.xml EX-101.PRE 8794
22 EXTRACTED XBRL INSTANCE DOCUMENT nby20230515_def14a_htm.xml XML 115289
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 23933673
SIC: 2834 Pharmaceutical Preparations